The discovery, characterization, and clinical development of glucagon-like-peptide-1 (GLP-1) spans more than 30 years and includes contributions from multiple investigators, science recognized by the 2017 Harrington Award Prize for Innovation in Medicine
Some patients get excellent results with natural protocols or benefit from combining medication with bioidentical hormone therapy to address perimenopausal weight gain
An intensive multifactorial cardiovascular risk intervention targeting glycemic, lipid and hypertension management, smoking and other lifestyle factors was shown to reduce the progression and development of cardiac autonomic neuropathy among patients with type 2 diabetes [15]
GLP-1 drugs have the potential to disrupt that model, because users are not simply eating less, they are eating differently. The end of food noise
These three amino acids contain important properties that our body produces separately, but when combined, they form an even stronger compound known as glutathione
In fact, more than 30% of North American patients with RA also carry obesity, and this group tends to cycle through more medications before finding relief